Toll Brothers stock outlook following its Q2 earnings

Toll Brothers Inc (NYSE: TOL) is already up 30% for the year but an RBC Capital analyst says the stock is still relatively inexpensive to own. Toll Brothers stock has another 15% upside On Thursday, Mike Dahl upgraded the luxury homebuilder to “outperform” and raised his price objective to $77 – up another 15% from… Continue reading Toll Brothers stock outlook following its Q2 earnings

IBEX 35 price forecast after yesterday’s red day for European equities

European equities tumbled yesterday as uncertainty dominates financial markets. With the debt ceiling deadline in the United States approaching fast, the bearishness of the US indices affects global equity markets. Diversification is key when building a portfolio. Several ways to diversify exist, and one is to diversify with other countries’ equities. As such, the Spanish… Continue reading IBEX 35 price forecast after yesterday’s red day for European equities

Activist investor TCS Capital wants Yelp to consider strategic options

Shares of Yelp Inc (NYSE: YELP) opened about 10% up this morning after an activist investor disclosed a sizable stake in the recommendation website operator. TCS wants Yelp to merge with Angi On Tuesday, TCS Capital Management pushed the California-based company to explore strategic options including a possible sale. The hedge fund owns over 4.0%… Continue reading Activist investor TCS Capital wants Yelp to consider strategic options

Jumia stock price: Africa’s Amazon faces a major forex risk

Jumia (NYSE: JMIA) stock price darted higher ahead of the latest financial results. The shares rose to a high of $3.15, much higher than the year-to-date low of $2.54. In all, Jumia shares have plunged by over 95% from the highest level in 2021. Jumia has a major forex risk Jumia Technologies is an e-commerce… Continue reading Jumia stock price: Africa’s Amazon faces a major forex risk

HEPA stock price surged but beware of this glaring Hepion risk

Hepion Pharmaceuticals’ (NASDAQ: HEPA) stock price went parabolic on Monday after the company made an important announcement about its mid-stage trial. The shares jumpd by more than 110% and reached a high of $19.66, the highest level since January 17. So, is Hepion a good pharma stock to buy? Hepion Pharmaceuticals trial One of the… Continue reading HEPA stock price surged but beware of this glaring Hepion risk

BT share price just received another catalyst as Drahi adds stake

BT Group (LON: BT.A) share price has jumped in the past four straight days as investors react to the recent earnings and investment by Patrick Drahi. The shares have risen by over 12.92% from the lowest level this month. In all, the stock has jumped by ~39% above the lowest level in 2022. BT Group… Continue reading BT share price just received another catalyst as Drahi adds stake